Quinolinic acid lesion induces changes in rat striatal glutathione metabolism

被引:15
作者
Cruz-Aguado, R [1 ]
Francis-Turner, L [1 ]
Díaz, CM [1 ]
Antúnez, I [1 ]
机构
[1] Int Ctr Neurol Restorat, Neurochem Lab, Havana 11300, Cuba
关键词
D O I
10.1016/S0197-0186(99)00165-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Although the involvement of oxidative mechanisms in the cytotoxicity of excitatory amino acids has been well documented, it is not known whether the intrastriatal injection of quinolinic acid (QA) induces changes in glutathione (GSH) metabolism. In this work, the activities of the enzymes GSH reductase (GRD), GSH peroxidase (GPX), and GSH S-transferase (GST), as well as the GSH content, were studied in the striatum, hippocampus, and frontal cortex of rats 1 and 6 weeks following the intrastriatal injection of QB (225 nmol). One group of animals remained untreated. This lesion resulted in a 20% decrease in striatal GRD activity at both the 1- and 6-week postlesion times, whereas GST exhibited a 30% activity increase in the lesioned striatum observable only 6 weeks after the lesion. GPX activity remained unchanged. In addition, the QA injection elicited a 30% fall in GSH level at the 1-week postlesion time. GSH related enzyme activities and GSH content from other areas outside the lesioned striatum were not affected. GST activation could represent a beneficial compensatory response to neutralize some of the oxidant agents generated by the lesion. However, this effect together with the reduction in GRD activity could be the cause or a contributing factor to the observed QA-induced deficit in GSH availability and, consequently, further disrupt the oxidant homeostasis of the injured striatal tissue. Therefore, these results provide evidence that the in vivo excitotoxic injury to the brain might affect oxidant/antioxidant equilibrium by eliciting changes in glutathione metabolism. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:53 / 60
页数:8
相关论文
共 40 条
  • [11] Bordelon YM, 1997, J NEUROCHEM, V69, P1629
  • [12] BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
  • [13] CARLBERG I, 1975, J BIOL CHEM, V250, P5475
  • [14] Cooper JL, 1992, MOL GENETIC BASIS NE, P209
  • [15] NGF prevents changes in rat brain glutathione-related enzymes following transection of the septohippocampal pathway
    Cruz-Aguado, R
    Francis-Turner, L
    Díaz-Suárez, CM
    Bergado, J
    [J]. NEUROCHEMISTRY INTERNATIONAL, 1999, 34 (02) : 125 - 130
  • [16] Role of glutathione metabolism in the glutamate-induced programmed cell death of neuronal-like PC12 cells
    Froissard, P
    Monrocq, H
    Duval, D
    [J]. EUROPEAN JOURNAL OF PHARMACOLOGY, 1997, 326 (01) : 93 - 99
  • [17] Fuchs O, 1997, NEOPLASMA, V44, P184
  • [18] Behavioral characterization of quinolinate-induced lesions of the medial striatum: Relevance for Huntington's disease
    Furtado, JCS
    Mazurek, MF
    [J]. EXPERIMENTAL NEUROLOGY, 1996, 138 (01) : 158 - 168
  • [19] Lesion of the nigrostriatal neurons by 6-hydroxydopamine induces changes in rat brain glutathione-S-transferase
    Garcia, JC
    Cruz, R
    Leiva, A
    Alvarez, P
    Soto, Y
    McPherson, M
    [J]. MOLECULAR AND CHEMICAL NEUROPATHOLOGY, 1997, 31 (02) : 149 - 159
  • [20] GerardMonnier D, 1996, PATHOL BIOL, V44, P77